{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T23:01:20Z","timestamp":1783033280195,"version":"3.54.6"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.chest.2016.10.003","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T16:58:14Z","timestamp":1476637094000},"page":"366-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions"],"prefix":"10.1016","volume":"151","author":[{"given":"Simon","family":"Couillard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Lariv\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Courteau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Vanasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chest.2016.10.003_bib1","unstructured":"Canadian Institute for Health Information (CIHI). Health Indicators 2008. Ottawa: CIHI; 2008. https:\/\/secure.cihi.ca\/free_products\/HealthIndicators2008_ENGweb.pdf. Accessed July 1, 2016."},{"key":"10.1016\/j.chest.2016.10.003_bib2","article-title":"2015 condition-specific measures updates and specifications report hospital-level 30-day risk-standardized readmission measures","author":"Dorsey","year":"2015","journal-title":"Centers Medicare Medicaid Serv"},{"issue":"5","key":"10.1016\/j.chest.2016.10.003_bib3","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCOUTCOMES.114.001364","article-title":"Hospital cardiovascular outcome measures in federal pay-for-reporting and pay-for-performance programs: a brief overview of current efforts","volume":"7","author":"Spivack","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9434","key":"10.1016\/j.chest.2016.10.003_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(04)16855-4","article-title":"Burden and clinical features of chronic obstructive pulmonary disease (COPD)","volume":"364","author":"Pauwels","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.chest.2016.10.003_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"suppl 6","key":"10.1016\/j.chest.2016.10.003_bib6","first-page":"261","article-title":"Eosinophilic airway inflammation in chronic obstructive pulmonary disease and asthma","volume":"59","author":"Gorska","year":"2008","journal-title":"J\u00a0Physiol Pharmacol"},{"key":"10.1016\/j.chest.2016.10.003_bib7","doi-asserted-by":"crossref","first-page":"S214","DOI":"10.1513\/AnnalsATS.201302-023AW","article-title":"Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease","volume":"10","author":"Brightling","year":"2013","journal-title":"Ann Am Thorac Soc"},{"issue":"6","key":"10.1016\/j.chest.2016.10.003_bib8","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2016.10.003_bib9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1183\/09031936.06.00072105","article-title":"Stable COPD: predicting benefit from high-dose inhaled corticosteroid treatment","volume":"27","author":"Leigh","year":"2006","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.chest.2016.10.003_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/thx.2004.032516","article-title":"Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease","volume":"60","author":"Brightling","year":"2005","journal-title":"Thorax"},{"issue":"9240","key":"10.1016\/j.chest.2016.10.003_bib11","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0140-6736(00)02872-5","article-title":"Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial","volume":"356","author":"Brightling","year":"2000","journal-title":"Lancet"},{"issue":"5 I","key":"10.1016\/j.chest.2016.10.003_bib12","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1164\/ajrccm.158.5.9804028","article-title":"Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis","volume":"158","author":"Pizzichini","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2016.10.003_bib13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.chest.2016.01.026","article-title":"Blood eosinophils and outcomes in severe hospitalized exacerbations of COPD","volume":"150","author":"Bafadhel","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.chest.2016.10.003_bib14","unstructured":"MacDonald MI, Osadnik CR, Qiu M, Vasanthakumar S, King P, Bardin PG. Eosinophilia is common in copd exacerbations and associated with non-infectious aetiology. In: C47. COPD: Exacerbations. American Thoracic Society; 2016. p. A5185-A5185. http:\/\/dx.doi.org\/10.1164\/ajrccm-conference.2016.193.1_MeetingAbstracts.A5185. Accessed July 1, 2016."},{"key":"10.1016\/j.chest.2016.10.003_bib15","unstructured":"Hambleton K, Shrimanker R, Russell R, Brightling CE, Pavord I, Bafadhel M. Defining inflammatory groups within a COPD cohort. In: B43. COPD: Phenotypes and Clinical Outcomes. American Thoracic Society; 2016. p. A3514-A3514. http:\/\/dx.doi.org\/10.1164\/ajrccm-conference.2016.193.1_MeetingAbstracts.A3514. Accessed July 1, 2016."},{"issue":"6","key":"10.1016\/j.chest.2016.10.003_bib16","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1183\/09031936.00162414","article-title":"Eosinophilic inflammation in COPD: prevalence and clinical characteristics","volume":"44","author":"Singh","year":"2014","journal-title":"Eur Respir J"},{"issue":"9","key":"10.1016\/j.chest.2016.10.003_bib17","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1164\/rccm.201509-1869OC","article-title":"Blood eosinophils and exacerbations in COPD: the Copenhagen General Population Study","volume":"193","author":"Vedel-Krogh","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.chest.2016.10.003_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09031936.00.15110900","article-title":"Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD","volume":"15","author":"Rutgers","year":"2000","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2016.10.003_bib19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.201502-0235LE","article-title":"Blood eosinophils: a biomarker of response to extrafine beclomethasone\/formoterol in chronic obstructive pulmonary disease","volume":"192","author":"Siddiqui","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2016.10.003_bib20","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophil counts, exacerbations, and response to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med"},{"issue":"15","key":"10.1016\/j.chest.2016.10.003_bib21","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM195110112451501","article-title":"Clinical studies on the activity of orally administered cortisone","volume":"245","author":"Thorn","year":"1951","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.chest.2016.10.003_bib22","unstructured":"Global Strategy for the Diagnosis Management and Prevention of COPD.\u00a0Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2016. http:\/\/www.goldcopd.org\/. Accessed July 1, 2016."},{"issue":"2","key":"10.1016\/j.chest.2016.10.003_bib23","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1023\/A:1024260023851","article-title":"A\u00a0Comparison of statistical modeling strategies for analyzing length of stay after CABG surgery","volume":"3","author":"Austin","year":"2002","journal-title":"Heal Serv Outcomes Res Methodol"},{"issue":"1","key":"10.1016\/j.chest.2016.10.003_bib24","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1183\/09031936.00207611","article-title":"A\u00a0trial of beclomethasone\/formoterol in COPD using EXACT-PRO to measure exacerbations","volume":"41","author":"Singh","year":"2013","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2016.10.003_bib25","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1164\/rccm.201108-1553OC","article-title":"Blood eosinophils to direct corticosteroid treatment of exacerbations of chronic obstructive pulmonary disease: a randomized placebo-controlled trial","volume":"186","author":"Bafadhel","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2016.10.003_bib26","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1182\/blood.V9.5.531.531","article-title":"The mechanism of glucocorticoid eosinopenia; contribution to the physiology of eosinophile granulocytes","volume":"9","author":"Essellier","year":"1954","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.chest.2016.10.003_bib27","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.4049\/jimmunol.147.10.3490","article-title":"Glucocorticoids inhibit cytokine-mediated eosinophil survival","volume":"147","author":"Wallen","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.chest.2016.10.003_bib28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.7326\/0003-4819-106-2-196","article-title":"Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease","volume":"106","author":"Anthonisen","year":"1987","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.chest.2016.10.003_bib29","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/rg.273065051","article-title":"Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview","volume":"27","author":"Jeong","year":"2007","journal-title":"Radiographics"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216607626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216607626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T07:33:43Z","timestamp":1757921623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216607626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0012369216607626"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2016.10.003","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726855270.793524830","asserted-by":"object"}]},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2016.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}